Avera Pharmaceuticals Raises $48M

San Diego-based Avera Pharmaceuticals, which is focused on developing medicines for psychiatric and neurologic illnesses, has raised $48M in a third round of funding. Financing came from Perseus-Soros BioPharmaceutical Fund and Schroder Ventures Life Sciences. New investors included Aberdare Ventures, BioAsia Investments, HIG Ventures, and Montreux Equity Partners. Prior investors also participated. More information »